Bimekizumab – Uses, Mechanism & Side Effects
Bimekizumab is a biologic medication used to treat psoriasis and other inflammatory conditions. It selectively blocks both IL-17A and IL-17F to reduce inflammation.
Things worth knowing about "Bimekizumab"
Bimekizumab is a biologic medication used to treat psoriasis and other inflammatory conditions. It selectively blocks both IL-17A and IL-17F to reduce inflammation.
What is Bimekizumab?
Bimekizumab is a monoclonal antibody belonging to the class of biologic medicines. It was developed to specifically target and suppress certain inflammatory processes in the body. The drug is marketed under the brand name Bimzelx and has received approval from the European Medicines Agency (EMA) as well as other regulatory authorities.
Indications
Bimekizumab is approved for the treatment of the following conditions in adults:
- Moderate to severe plaque psoriasis when other treatments have been inadequate or not tolerated
- Active psoriatic arthritis (joint inflammation associated with psoriasis)
- Ankylosing spondylitis (Bechterew disease) and non-radiographic axial spondyloarthritis
- Hidradenitis suppurativa (acne inversa), a chronic skin condition
Mechanism of Action
Bimekizumab is a dual IL-17A and IL-17F inhibitor. This means it simultaneously blocks two key signalling proteins of the immune system: interleukin-17A (IL-17A) and interleukin-17F (IL-17F).
Both of these interleukins play a central role in driving the inflammatory responses characteristic of diseases such as plaque psoriasis and spondyloarthritis. By blocking both proteins at once, bimekizumab can suppress inflammation more comprehensively than agents that target IL-17A alone.
Administration and Dosage
Bimekizumab is administered as a subcutaneous injection, meaning it is injected under the skin using a pre-filled pen or syringe. After appropriate training, patients can self-administer the injection at home.
The recommended dosage depends on the condition being treated:
- Plaque psoriasis: 320 mg every 4 weeks during the induction phase, then every 8 weeks
- Psoriatic arthritis and spondyloarthritis: 160 mg every 4 weeks
- Hidradenitis suppurativa: 320 mg every 2 weeks during the induction phase, then every 4 weeks
Dosage should always be determined by the treating physician based on individual patient needs.
Side Effects
Like all biologic therapies, bimekizumab may cause side effects. The most commonly reported include:
- Upper respiratory tract infections (e.g., runny nose, sore throat)
- Oral candidiasis (fungal infections in the mouth and throat) – a characteristic effect of IL-17 inhibition
- Injection site reactions
- Headache
- Elevated liver enzyme levels
Less common but serious side effects include severe infections and possible worsening of inflammatory bowel diseases such as Crohn's disease.
Contraindications and Precautions
Bimekizumab should not be used in patients with:
- Active, serious infections (e.g., active tuberculosis)
- Known hypersensitivity to the active substance or any of the excipients
A tuberculosis screening is recommended before initiating treatment. Patients with a history of inflammatory bowel disease should be monitored closely. Use during pregnancy and breastfeeding should only be considered after careful assessment of benefits and risks by the treating physician.
Treatment Context
Bimekizumab is typically prescribed when conventional therapies (e.g., methotrexate, ciclosporin) or other biologics (e.g., TNF inhibitors) have proven insufficient or poorly tolerated. It belongs to the modern class of targeted immunotherapies and represents an effective treatment option for many patients with difficult-to-treat psoriasis or spondyloarthritis.
References
- European Medicines Agency (EMA): Bimzelx (bimekizumab) – Summary of Product Characteristics. Available at: https://www.ema.europa.eu (accessed 2024)
- Gordon KB et al. – Bimekizumab versus Secukinumab in Plaque Psoriasis. New England Journal of Medicine, 2023.
- Deodhar A et al. – Bimekizumab in Patients with Active Ankylosing Spondylitis. The Lancet, 2021.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryWinter itch
Sigmoid diverticulitis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Bimekizumab